Does maintenance azithromycin reduce asthma exacerbations? An individual participant data meta-analysis

Sarah A. Hiles, Vanessa M. McDonald, Michelle Guilhermino, Guy G. Brusselle, Peter G. Gibson

Source: Eur Respir J, 54 (5) 1901381; 10.1183/13993003.01381-2019
Journal Issue: November
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Sarah A. Hiles, Vanessa M. McDonald, Michelle Guilhermino, Guy G. Brusselle, Peter G. Gibson. Does maintenance azithromycin reduce asthma exacerbations? An individual participant data meta-analysis. Eur Respir J, 54 (5) 1901381; 10.1183/13993003.01381-2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Does long-term macrolide treatment reduce asthma exacerbations? An individual patient data meta-analysis
Source: International Congress 2019 – Clinical studies of asthma treatments
Year: 2019

How to reduce COPD exacerbations with inhaled drugs? A pooled analysis of randomized trials
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008

Systematic review: Does antibiotic treatment duration affect the outcomes of asthma and COPD exacerbations?
Source: International Congress 2017 – COPD: microbiome composition and the role of antibiotics
Year: 2017



Omalizumab reduces asthma exacerbations and oral corticosteroid use in patients with severe allergic asthma: a systematic review of observational studies
Source: International Congress 2019 – Clinical studies of asthma treatments
Year: 2019


The cost-effectiveness of azithromycin in reducing exacerbations in uncontrolled asthma
Source: Eur Respir J, 57 (2) 2002436; 10.1183/13993003.02436-2020
Year: 2021



Is antibiotic treatment during asthma exacerbation necessary ?
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017


Does adherence to inhaled corticosteroids predict asthma-related outcomes over time? A cohort study
Source: Eur Respir J, 54 (6) 1900901; 10.1183/13993003.00901-2019
Year: 2019



Persistence to COPD therapies and impact on exacerbations: a French claims data study
Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Year: 2018




Heterogeneity and time course of asthma exacerbations: data from AUSTRI
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021


Could montelukast reduce asthma exacerbations?
Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases
Year: 2008

Preventing asthma exacerbations with budesonide/formoterol maintenance + relief: a pooled analysis
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II
Year: 2008

Late Breaking Abstract - Can a self-management plan, which includes a four-fold increase in inhaled corticosteroid dose, reduce severe asthma exacerbations: a randomised, pragmatic trial.
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017

Can antibiotics prevent acute COPD exacerbation? A systematic review and meta-analysis
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013

Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013

Telithromycin for acute exacerbations of asthma: pulmonary function data from the TELICAST study
Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population
Year: 2005


Inhaled corticosteroid withdrawal may improve outcomes in elderly patients with COPD exacerbation: a nationwide database study
Source: ERJ Open Res, 6 (1) 00246-2019; 10.1183/23120541.00246-2019
Year: 2020



Effect of high or low-medium accumulated dose regimes of systemic corticosteroids for hospitalised patients with exacerbated chronic obstructive pulmonary disease: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials
Source: Virtual Congress 2021 – COPD pharmacology: from basic science to real-world data
Year: 2021



Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?
Source: Eur Respir J, 57 (2) 2002122; 10.1183/13993003.02122-2020
Year: 2021



A global survey conducted to determine frequency of exacerbations in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013


Inhaled antibiotic treatment reduces the frequency of infective exacerbations in bronchiectasis: a single center, real life study
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019